These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8750616)

  • 1. Plasma creatine kinase and cardiomyopathy in glycogen storage disease type III.
    Lee P; Burch M; Leonard JV
    J Inherit Metab Dis; 1995; 18(6):751-2. PubMed ID: 8750616
    [No Abstract]   [Full Text] [Related]  

  • 2. [Glycogenosis type III myocardiopathy].
    Rossignol AM; Meyer M; Rossignol B; Palcoux MP; Raynaud EJ; Bost M
    Arch Fr Pediatr; 1979 Mar; 36(3):303-9. PubMed ID: 158352
    [No Abstract]   [Full Text] [Related]  

  • 3. A simple, rapid test for the differential diagnosis of glycogen storage disease type 3.
    Bhuiyan J; Al Odaib AN; Ozand PT
    Clin Chim Acta; 2003 Sep; 335(1-2):21-6. PubMed ID: 12927680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycogen storage disease type III (glycogen debranching enzyme deficiency): correlation of biochemical defects with myopathy and cardiomyopathy.
    Coleman RA; Winter HS; Wolf B; Gilchrist JM; Chen YT
    Ann Intern Med; 1992 Jun; 116(11):896-900. PubMed ID: 1580445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiomyopathy in glycogen-storage disease type III: clinical and echographic study of 18 patients.
    Labrune P; Huguet P; Odievre M
    Pediatr Cardiol; 1991 Jul; 12(3):161-3. PubMed ID: 1876514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiomyopathy of glycogen storage disease type III.
    Carvalho JS; Matthews EE; Leonard JV; Deanfield J
    Heart Vessels; 1993; 8(3):155-9. PubMed ID: 8407725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of severe cardiomyopathy in glycogen storage disease type III With D,L-3-hydroxybutyrate, ketogenic and high-protein diet.
    Valayannopoulos V; Bajolle F; Arnoux JB; Dubois S; Sannier N; Baussan C; Petit F; Labrune P; Rabier D; Ottolenghi C; Vassault A; Broissand C; Bonnet D; de Lonlay P
    Pediatr Res; 2011 Dec; 70(6):638-41. PubMed ID: 21857385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical sequelae of 17 cases with glycogen storage disease type II/Pompe disease].
    Zhang HB; Zhang WM; Qiu JJ; Meng Y; Qiu ZQ
    Zhonghua Er Ke Za Zhi; 2012 Jun; 50(6):415-9. PubMed ID: 22931935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type III glycogen storage disease: an adult case with mild disease but complete absence of debrancher protein.
    Yang BZ; Stewart C; Ding JH; Chen YT
    Neuromuscul Disord; 1991; 1(3):173-6. PubMed ID: 1822791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac involvement in glycogen storage disease type III.
    Moses SW; Wanderman KL; Myroz A; Frydman M
    Eur J Pediatr; 1989 Aug; 148(8):764-6. PubMed ID: 2792130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen storage disease type III in Egyptian children: a single centre clinico-laboratory study.
    El-Karaksy H; Anwar G; El-Raziky M; Mogahed E; Fateen E; Gouda A; El-Mougy F; El-Hennawy A
    Arab J Gastroenterol; 2014 Jun; 15(2):63-7. PubMed ID: 25097048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific heart muscle disease associated with glycogen storage disease type III: clinical similarity to the dilated phase of hypertrophic cardiomyopathy.
    Akazawa H; Kuroda T; Kim S; Mito H; Kojo T; Shimada K
    Eur Heart J; 1997 Mar; 18(3):532-3. PubMed ID: 9076400
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuromuscular involvement in glycogen storage disease type III.
    Moses SW; Gadoth N; Bashan N; Ben-David E; Slonim A; Wanderman KL
    Acta Paediatr Scand; 1986 Mar; 75(2):289-96. PubMed ID: 3457519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of glycogen storage disease type IIIa-related cardiomyopathy with modification of diet.
    Dagli AI; Zori RT; McCune H; Ivsic T; Maisenbacher MK; Weinstein DA
    J Inherit Metab Dis; 2009 Dec; 32 Suppl 1(0 1):S103-6. PubMed ID: 19322675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of blood level of muscle enzymes in glycogenoses with liver involvement: a diagnostic criterion].
    Labrune P; Chalas J; Pignon JP; Hennion C; Odièvre M
    Ann Pediatr (Paris); 1989 May; 36(5):299-301. PubMed ID: 2742313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic significance of creatine kinase mass in children with myocardial injury].
    Liu S; Wang H; Wang XY; Yu XY
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Jun; 23(6):363-4. PubMed ID: 21672387
    [No Abstract]   [Full Text] [Related]  

  • 17. [Amylo-1,6-glucosidase deficiency-glucogenosis (glycogen debranching enzyme). Report of a case with functional and histologic enzyme studies].
    Hernández-Pando R; Velázquez A; Mallet A; Chambers JP; Williams JC; Prieto E
    Bol Med Hosp Infant Mex; 1983 Jul; 40(7):386-92. PubMed ID: 6578799
    [No Abstract]   [Full Text] [Related]  

  • 18. Glycogen storage disease: recommendations for treatment.
    Fernandes J; Leonard JV; Moses SW; Odièvre M; di Rocco M; Schaub J; Smit GP; Ullrich K; Durand P
    Eur J Pediatr; 1988 Apr; 147(3):226-8. PubMed ID: 3292244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycogen storage disease type III. A case report.
    de Waal A; Röhm GF; Hoek BB; Potgieter GM; Oosthuysen WT
    S Afr Med J; 1984 Jan; 65(1):23-5. PubMed ID: 6320474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis of glycogen storage disease type IIIA by detecting glycogen debranching enzyme activity, glycogen content and structure in muscle].
    Wang W; We M; Song HM; Qiu ZQ; Zhang WM; Wu XY; Lu CX; Qi JM; Jing H; Li F
    Zhonghua Er Ke Za Zhi; 2009 Aug; 47(8):608-12. PubMed ID: 19951495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.